Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_assertion type Assertion NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_head.
- NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_assertion wasGeneratedBy ECO_0000203 NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_provenance.
- NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_assertion wasDerivedFrom befree-2016 NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_provenance.
- NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_assertion SIO_000772 22488406 NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_provenance.
- NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_assertion evidence source_evidence_literature NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_provenance.
- NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_assertion description "[A high MEBE score, defined as high expression of at least two of the four genes, predicted a significantly shorter overall survival (OS) (HR 2.29, 95 % CI 1.3-4.09, P= .005) and time to AML progression (HR 4.83, 95 % CI 2.01-11.57, P< .001) compared to a low MEBE score in multivariate analysis independent of karyotype, percentage of bone marrow blasts, transfusion dependence, ASXL1, and IDH1 mutation status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973493.RAoessgW2_me0XpsnCOU8Pxr9ofQGHXJwb9c-VT1_6-M0130_provenance.